EPLR Journal

+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
First Issue in Summer 2017: EPLR 1/2017

Lexxion Publisher and renowned experts in the field of pharmaceutical law are currently developing a new journal focused on pharmaceutical matters and trends - the European Pharmaceutical Law Review (EPLR). The first issue will be published in summer 2017.

You are interested in contributing to the journal? View our Call for Papers.

You want to stay informed about the publication and upcoming special offers? Sign up for our newsletter.

More information coming soon!
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +

Publication frequency: quarterly
approx. 70 pages

Special Offer

 

European Pharmaceutical Law Review - EPLR

The European Pharmaceutical Law Review (EPLR) reports on key legislative developments in the EU and the Member States, and identifies and analyses important judgments that shape the interpretation and application of EU pharmaceutical law, in particular those by the European Courts, international courts and tribunals such as the WTO's Dispute Settlement Body, and higher national courts.

In order to establish itself as a forum for dialogue between different stakeholders in pharmaceutical regulation and governance, it will invite contributions from academics, practitioners, regulators and civil society representatives.

Topics covered by EPLR include:

  • Pharmaceutical law and policy in all jurisdictions (regional, national, international);
  • Commission decisions (EMA opinions) and regulatory guidelines;
  • National EU, and International Jurisprudence;
  • Medical devices;
  • Borderline cases: pharmaceuticals/food/cosmetics/chemicals
  • Patents /Trademarks;
  • Health Technology Assessment and pricing/reimbursement;
  • Digital health/Big data;

All contributions will be subject to double blind peer-review before acceptance for publication and are required to conform to the author guidelines.

EPLR's Target Audience

The quarterly addresses everyone who is concerned with pharmaceutical law and policy issues such as academics (in the field of law, pharmacists, and other relevant research fields), legal practitioners in national and international law firms, government officials working in EU public administration, judges and legal experts in domestic, European and international courts, consultancies, business people in the EU and beyond as well as stakeholder organisations representing professionals, patients, and civil society.

EPLR's Structure

Each issue of EPLR will be a balanced mixture of original research articles, first-hand country or thematic policy reports, timely case annotations on important ECJ/GC rulings and other international/national court judgments, book reviews as well as other information material and updates, including opinions, case summaries or event reports.

 

Managing Editor

Sabrina Wirtz
Maastricht University

 

Editorial Board



Ulrich M. Gassner
University of Augsburg

Leigh Hancher
University of Tilburg / Allen & Overy

Trudo Lemmens
University of Toronto

Alessandro Spina
European Medicines Agency

Karin Verzijden
Axon Lawyers

 
 
 

EXECUTIVE EDITOR

ch

Olga Hog

Tel.: +49 30-81 45 06-2924
hog@lexxion.de

 

CUSTOMER SERVICE

  (orders, enquiries, returns)

  Cristina Gîrloanƫă
Tel.: +49 30-81 45 06-12
mail@lexxion.de

EStAL
Journal
Publication frequency: quarterly
Subscription: € 442,-
ISSN 16 19-52 72

Further information